← Back to Search

Hormone Therapy

Carbohydrate restricted dietary intervention for Breast Cancer

Q: Has the FDA acknowledged Carbohydrate restricted dietary intervention as an accepted practice?

Carbohydrate restricted dietary intervention is at a Phase 2, meaning while there is some data supporting safety, none yet supports efficacy. Our team has given it a score of 2.

Q: Are patients currently being enrolled in this trial?

That is correct. As of today, the study detailed on clinicaltrials.gov is still recruiting patients. This research was initially posted on February 4th, 2020 and was most recently updated on June 30th, 2022. In total, 40 individuals are needed for this project taking place at a single site.

Q: How many test subjects are required for this clinical trial?

The correct answer is that this study is actively recruiting patients, as shown by the information on clinicaltrials.gov. This particular trial was first posted on February 4th 2020 and has been updated as recently as June 30th 2022. The research team is looking for 40 people to participate at 1 location.

Phase 2

Waitlist Available

Led By Farin Amersi, MD

Research Sponsored by Farin Amersi

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

Study Summary

This trial is testing a very low carbohydrate diet to see if it helps with a particular medical treatment.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Mean change in weight

Secondary outcome measures

Changes in HDL

Changes in HbA1c

Changes in LDL

+5 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Dietary interventionExperimental Treatment2 Interventions

Carbohydrate restricted dietary intervention (<20 g carbohydrates/day) + standard of care aromatase inhibitors

Group II: No dietary interventionActive Control1 Intervention

Standard of care aromatase inhibitors

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Farin AmersiLead Sponsor

Farin Amersi, MD5.030 ReviewsPrincipal Investigator - Cedars-Sinai Medical Center

Cedars-Sinai Medical Center

5Patient Review

Thorough and personable, this was the best surgical experience I have had to date.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has the FDA acknowledged Carbohydrate restricted dietary intervention as an accepted practice?

"Carbohydrate restricted dietary intervention is at a Phase 2, meaning while there is some data supporting safety, none yet supports efficacy. Our team has given it a score of 2."

Answered by AI

Are patients currently being enrolled in this trial?

"That is correct. As of today, the study detailed on clinicaltrials.gov is still recruiting patients. This research was initially posted on February 4th, 2020 and was most recently updated on June 30th, 2022. In total, 40 individuals are needed for this project taking place at a single site."

Answered by AI

How many test subjects are required for this clinical trial?

"The correct answer is that this study is actively recruiting patients, as shown by the information on clinicaltrials.gov. This particular trial was first posted on February 4th 2020 and has been updated as recently as June 30th 2022. The research team is looking for 40 people to participate at 1 location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

BREADS: Breast Adjuvant Diet Study

Farin Amersi 2020. "BREADS: Breast Adjuvant Diet Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04189263.